{"schema_version":"secwatch.filing_event.v1","accession":"0001038074-26-000027","form_type":"8-K","ticker":"SLAB","cik":"0001038074","company_name":"SILICON LABORATORIES INC.","filed_at":"2026-08-11T20:14:32+00:00","discovered_at":"2026-08-11T20:15:05.518844+00:00","generated_at":"2026-08-11T20:15:16.084608+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Silicon Labs Q2 revenue $228M (+18% YoY); non-GAAP EPS $0.71, up 545%","bullets":["Revenue $228M, up 18% YoY; Industrial & Commercial $135M (+23%), Home & Life $93M (+12%).","Non-GAAP diluted EPS $0.71 (+545% YoY); GAAP diluted loss/share $(0.32), improved 52% YoY.","GAAP gross margin 61.6%; non-GAAP gross margin 61.9%; GAAP operating loss $11M; non-GAAP operating income $27M.","Medical segment set record revenue, up 78% YoY; bookings, design wins accelerated; channel inventory declined.","Forward guidance suspended due to pending Texas Instruments acquisition; merger costs excluded from non-GAAP."],"urls":{"canonical":"https://secwatch.observer/filing/0001038074-26-000027","json":"https://secwatch.observer/filing/0001038074-26-000027.json","markdown":"https://secwatch.observer/filing/0001038074-26-000027.md","text":"https://secwatch.observer/filing/0001038074-26-000027.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1038074/000103807426000027/0001038074-26-000027-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1038074/000103807426000027/slab-20260811.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-11T20:15:16.084608+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}